Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,572 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07265232RecruitingPhase 3
Gene therapy for spinal muscular atrophy in low-resource settings
This trial tests a new gene therapy called Vesemnogene Lantuparvovec for people with spinal muscular atrophy (SMA). It is designed for patients in low- and middle-income countries who cannot access or did not respond to other treatments. The goal is to see if the therapy is safe and effective in real-world conditions.
Jakarta, IndonesiaAges 6 months+ - NCT07266545RecruitingPhase 4
RNA markers for antidepressant response in depression
This study looks at how RNA might help predict which antidepressant works best for you. It tests two medications: vortioxetine and cariprazine, in people with major depressive disorder or bipolar depression.
Rochester, MinnesotaAges 18–65 - NCT07267130RecruitingPhase 1
Safety study of TQC3302 inhaler in healthy adults
This trial tests a new inhaled medication (TQC3302) in healthy adults to see if it is safe and how the body processes it. It is a first-in-human study for a potential treatment for lung conditions.
Beijing, Beijing MunicipalityAges 18–55 - NCT07267949RecruitingPhase 2
Study of AP31969 for atrial fibrillation rhythm control
This study tests a new medication, AP31969, to control heart rhythm in people with atrial fibrillation. It compares the drug to a placebo to see if it can reduce how often AF episodes happen over time.
Plovdiv, PDAges 18 years+ - NCT07268053RecruitingEarly Phase 1
B7-H3 drug for recurrent brain tumor or brain metastases
This trial tests a drug called GSK5764227 (a B7-H3 targeted antibody-drug conjugate) in people whose glioblastoma has come back after standard treatment, or who have brain metastases that need surgery. The goal is to see if the drug can help shrink or control the tumor.
Phoenix, ArizonaAges 18 years+ - NCT07268326Recruiting
Plant-based diet for rheumatoid arthritis
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
FrederiksbergAges 18 years+ - NCT07270003Recruiting
Ivarmacitinib for palmoplantar pustulosis
This trial tests a new oral medication, ivarmacitinib, for adults with palmoplantar pustulosis (PPP) who haven't gotten better with standard treatments. It aims to see if the drug is safe and effective for reducing the painful pustules on the palms and soles.
Xi'an, ShaanxiAges 18 years+ - NCT07270744Recruiting
Lung Sound Study with Eko Devices
This study uses a digital stethoscope to record lung sounds from adults with or without lung conditions. It aims to collect data that may help improve detection of breathing problems.
Mumbai, MaharashtraAges 18 years+ - NCT07270757Recruiting
Pre-ablation exercise program for atrial fibrillation
This study tests whether a short exercise and education program before a first-time ablation for atrial fibrillation improves your recovery and heart fitness. It's for people with mild or no heart failure symptoms and a well-pumping heart.
Nanjing, Please SelectAges 18–70 - NCT07273188RecruitingEarly Phase 1
PET scan to measure gut scarring in Crohn's disease
This study tests a new PET scan with a tracer called 68Ga-FAPI-46 to see how well it can find and measure scarring (fibrosis) in the small bowel caused by Crohn's disease. It may help doctors better understand and manage bowel damage.
Rochester, MinnesotaAges 18 years+ - NCT07274436Recruiting
Deep learning in heart MRI scans
This study uses artificial intelligence to improve the quality of heart MRI images. It may help doctors get clearer pictures of your heart.
Wuhan, HubeiAges 18 years+ - NCT07275021Recruiting
Brain Injury & Vision Screening in Newborns
This study looks for early signs of vision problems in babies who had brain injuries around the time of birth. It aims to help doctors better identify and predict these issues.
Boston, MassachusettsAges 7 months–10 months - NCT07275515RecruitingPhase 2
Diroximel fumarate for brain bleed swelling
This study tests a medicine called diroximel fumarate to reduce swelling around a bleeding stroke (intracerebral hemorrhage). If you or your loved one have had a brain bleed within the last 48 hours and are not too severely affected, you may be able to join.
LilleAges 18 years+ - NCT07275879Recruiting
Quality of life with a new ureteral stent
This study tests a modified double J stent to see how it affects your quality of life. If you have kidney or ureter stones, this trial may help improve comfort during treatment.
Saint Petersburg, Outside U.S./CanadaAges 18 years+ - NCT07276542RecruitingPhase 2/Phase 3
Ketamine for phantom limb pain: a six-month outpatient study
This study tests whether ketamine, given as an outpatient treatment, can reduce phantom limb pain over six months. You would come to a clinic for multiple ketamine sessions, with at least a week between each session, and be followed for a year.
Sacramento, CaliforniaAges 18–65 - NCT07277608Recruiting
Study on sleep apnea patients and their health over time
This study looks at patients with suspected or confirmed obstructive sleep apnea (a condition where breathing stops and starts during sleep) to understand the condition better. Researchers will follow patients for at least one year to learn more about the underlying causes and how it affects health.
Beijing, Beijing MunicipalityAges Any age - NCT07278700Recruiting
Fever and respiratory infection study
This study looks at adults with a fever caused by a respiratory infection. If you qualify, you will have a blood draw as part of your regular care, and researchers will use it to learn more about your condition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07278843Recruiting
Understanding vision loss in Usher syndrome type 1B
This study follows people with Usher syndrome type 1B over time to learn how vision loss progresses. It also tests new ways to measure functional vision, which may help design future treatments.
Paris, Île-de-France RegionAges 3–75 - NCT07279649Recruiting
Studying a stent for blood vessel disease
This study is tracking how well a specific stent (GORE® VIABAHN® VBX) works over time in people who need treatment for narrowed or blocked blood vessels. It aims to see if the stent helps keep blood flowing long-term.
MunichAges 18 years+ - NCT07280156RecruitingPhase 2
Study of PRX-115 for gout with or without methotrexate
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
Little Rock, ArkansasAges 18 years+ - NCT07280260RecruitingPhase 4
Testing a new dental implant system for replacing a missing back tooth
This trial tests the Nobel N1 dental implant system in people missing a single back tooth. It aims to see how well the implant works when a replacement tooth is placed right away.
New Orleans, LouisianaAges 18 years+ - NCT07280312Recruiting
Ultrasound imaging test for ovarian lesions
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
Rochester, MinnesotaAges 18 years+ - NCT07280832RecruitingPhase 1/Phase 2
Study of JMT108 for advanced melanoma
This trial tests a new drug, JMT108, for people with advanced melanoma that can't be removed by surgery or has spread. It's for those who have tried other treatments or have no good options left.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07281014RecruitingPhase 4
Testing a different approach to heart failure medication
This trial is for people with stable, mild heart failure. It tests a new way of using a standard medicine (spironolactone) to see if it works better at a different dose. The study lasts 8 weeks.
New Haven, ConnecticutAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,572 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.